Biological Mimetics
Biological Mimetics, Inc. (BMI) is a leading biomedical company founded in 1996, dedicated to innovating in vaccine development and diagnostics. The company integrates biology and engineering to identify and prevent global infections, employing proprietary platforms such as Immune Refocusing Technology (IRT), ultra UVC irradiation, and FAST chip diagnostics. BMI's mission is to improve public health by combating resistant and emerging diseases in human and veterinary medicine, with a focus on underrepresented targets including viral, bacterial, and parasitic pathogens.
Industries
Nr. of Employees
small (1-50)
Biological Mimetics
Products
Multi-chamber disposable microfluidic diagnostic device (instrument-free)
A disposable, multi-chamber microfluidic device preloaded with reagents that enables sample disruption, isothermal amplification, and CRISPR-based optical readout without electrical power or pipettes.
UVC inactivation vaccine platform with MDP formulation
Inactivated vaccine approach that complexes pathogens with an MDP formulation prior to UVC irradiation to produce inactivated immunogens intended for vaccine development.
Ellipsometry-based rapid bacterial detection assay
A rapid diagnostic assay using ellipsometry-based sensing to detect and characterize bacterial infections for rapid clinical decision-making.
Multi-chamber disposable microfluidic diagnostic device (instrument-free)
A disposable, multi-chamber microfluidic device preloaded with reagents that enables sample disruption, isothermal amplification, and CRISPR-based optical readout without electrical power or pipettes.
UVC inactivation vaccine platform with MDP formulation
Inactivated vaccine approach that complexes pathogens with an MDP formulation prior to UVC irradiation to produce inactivated immunogens intended for vaccine development.
Ellipsometry-based rapid bacterial detection assay
A rapid diagnostic assay using ellipsometry-based sensing to detect and characterize bacterial infections for rapid clinical decision-making.
Services
Collaborative R&D and sponsored-project management
Coordination and execution of grant-funded research programs, partnerships with academic and government collaborators, milestone reporting, and grant administration.
Preclinical manufacturing and IND-enabling study support
Production of GLP/GMP-like lots for animal safety and efficacy studies and preparation of regulatory documentation to support IND submissions.
Diagnostic prototype development and beta-testing support
Development of low-cost, instrument-free diagnostic prototypes integrating isothermal amplification and CRISPR detection, and coordination of beta-testing with collaborators and blinded sample providers.
Collaborative R&D and sponsored-project management
Coordination and execution of grant-funded research programs, partnerships with academic and government collaborators, milestone reporting, and grant administration.
Preclinical manufacturing and IND-enabling study support
Production of GLP/GMP-like lots for animal safety and efficacy studies and preparation of regulatory documentation to support IND submissions.
Diagnostic prototype development and beta-testing support
Development of low-cost, instrument-free diagnostic prototypes integrating isothermal amplification and CRISPR detection, and coordination of beta-testing with collaborators and blinded sample providers.
Expertise Areas
- Vaccine design and development
- Point-of-care nucleic acid diagnostics
- Computational immunology and epitope prediction
- Biosensor engineering and nanoparticle-enabled sensing
Key Technologies
- CRISPR-based diagnostics (Cas12a/Cas13a)
- Isothermal amplification (RPA)
- Microfluidic multi-chamber disposable chips
- UVC inactivation with manganese-decapeptide-phosphate (MDP)